HIGH DOSE MELPHALAN AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN HIGH RISK MYELOMA
1987; Wiley; Volume: 67; Issue: 4 Linguagem: Inglês
10.1111/j.1365-2141.1987.tb06175.x
ISSN1365-2141
AutoresJ. L. Harousseau, Nöel Milpied, Richard Garand, J. H. Bourhis,
Tópico(s)Hematopoietic Stem Cell Transplantation
ResumoBritish Journal of HaematologyVolume 67, Issue 4 p. 493-493 Free Access HIGH DOSE MELPHALAN AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN HIGH RISK MYELOMA J. L. Harousseau, J. L. Harousseau Service d'Hématologie Clinique, Centre Hospitaller Regional et Universitaire de Nantes, Hôtel Dieu, Place Alexis Ricordeau, 1005–44035 Nantes Cedex 01, FranceSearch for more papers by this authorN. Milpied, N. Milpied Service d'Hématologie Clinique, Centre Hospitaller Regional et Universitaire de Nantes, Hôtel Dieu, Place Alexis Ricordeau, 1005–44035 Nantes Cedex 01, FranceSearch for more papers by this authorR. Garand, R. Garand Service d'Hématologie Clinique, Centre Hospitaller Regional et Universitaire de Nantes, Hôtel Dieu, Place Alexis Ricordeau, 1005–44035 Nantes Cedex 01, FranceSearch for more papers by this authorJ. H. Bourhis, J. H. Bourhis Service d'Hématologie Clinique, Centre Hospitaller Regional et Universitaire de Nantes, Hôtel Dieu, Place Alexis Ricordeau, 1005–44035 Nantes Cedex 01, FranceSearch for more papers by this author J. L. Harousseau, J. L. Harousseau Service d'Hématologie Clinique, Centre Hospitaller Regional et Universitaire de Nantes, Hôtel Dieu, Place Alexis Ricordeau, 1005–44035 Nantes Cedex 01, FranceSearch for more papers by this authorN. Milpied, N. Milpied Service d'Hématologie Clinique, Centre Hospitaller Regional et Universitaire de Nantes, Hôtel Dieu, Place Alexis Ricordeau, 1005–44035 Nantes Cedex 01, FranceSearch for more papers by this authorR. Garand, R. Garand Service d'Hématologie Clinique, Centre Hospitaller Regional et Universitaire de Nantes, Hôtel Dieu, Place Alexis Ricordeau, 1005–44035 Nantes Cedex 01, FranceSearch for more papers by this authorJ. H. Bourhis, J. H. Bourhis Service d'Hématologie Clinique, Centre Hospitaller Regional et Universitaire de Nantes, Hôtel Dieu, Place Alexis Ricordeau, 1005–44035 Nantes Cedex 01, FranceSearch for more papers by this author First published: December 1987 https://doi.org/10.1111/j.1365-2141.1987.tb06175.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Selby, P.J., McEIwain, T. J., Nandi, A.C., Perren, T.J., Powles, R.J., Tillyer, C.R., Osborne, R.J., Slevin, MX. & Malpas, J.S. (1987) Multiple myeloma treated with high dose intravenous melphalan. British Journal of Haematology, 66, 55–62. McEIwain, T.J. & Powles, R.L. (1983) High dose intravenous melphalan for plasma cell leukaemia and myeloma. Lancet, ii, 822–824. Barlogie, B., Hall, R., Zander, A., Dicke, K. & Alexanian, R. (1986) High dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood, 67, 1298–1301. Barlogie, B., Alexanian, R., Dicke, K.A. & Zagars, G. (1987) High dose Melphalan (HDM) and total body irradiation for refractory multiple myeloma. Proceedings ASCO, Abstract 757. Citing Literature Volume67, Issue4December 1987Pages 493-493 ReferencesRelatedInformation
Referência(s)